Synageva BioPharma Corp. (GEVA) was a big mover last session, as its shares rose over 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend for the company, as the stock is now trading above the volatile price range of $62.76 to $69.26 in the past one-month time frame.
In the last 30 days, the company did not witness any estimate revision and the Zacks Consensus Estimate also remained unchanged. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
Synageva BioPharma currently has a Zacks Rank #3 (Hold) while its Earnings ESP is positive.
Some better-ranked biomedical stocks include Halozyme Therapeutics, Inc. (HALO), Merrimack Pharmaceuticals, Inc. (MACK) and Myriad Genetics Inc. (MYGN). All three sport a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
To read this article on Zacks.com click here.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
Be the first to comment